FIRU Engine tests the patients' brain CT scan data, vital signs, laboratory tests, medical history against predefined rules for stroke detection & management and display the results for each patient.
CT Scan | Blood Levels | Hypertension | Diabetes | |
---|---|---|---|---|
Patient 1 |
DATA: Hyperdense area: no Sudden onset neuro sypmtoms: no |
DATA: Glucose: 288 Acute stroke symptoms: yes Age: 16 |
DATA: History: no Blood Pressure: 33 |
DATA: Hemoglobin A1c: 7.22% |
ACTION: - |
ACTION: - |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 2 |
DATA: Hyperdense area: yes Sudden onset neuro sypmtoms: no |
DATA: Glucose: 244 Acute stroke symptoms: no Age: 72 |
DATA: History: no Blood Pressure: 79 |
DATA: Hemoglobin A1c: 54.48% |
ACTION: - |
ACTION: - |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 3 |
DATA: Hyperdense area: yes Sudden onset neuro sypmtoms: no |
DATA: Glucose: 124 Acute stroke symptoms: no Age: 56 |
DATA: History: yes Blood Pressure: 114 |
DATA: Hemoglobin A1c: 50.44% |
ACTION: - |
ACTION: - |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 4 |
DATA: Hyperdense area: no Sudden onset neuro sypmtoms: no |
DATA: Glucose: 194 Acute stroke symptoms: yes Age: 70 |
DATA: History: no Blood Pressure: 142 |
DATA: Hemoglobin A1c: 68.73% |
ACTION: - |
ACTION: Monitor Hyperglycemia-related Complications |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 5 |
DATA: Hyperdense area: yes Sudden onset neuro sypmtoms: no |
DATA: Glucose: 130 Acute stroke symptoms: yes Age: 74 |
DATA: History: yes Blood Pressure: 131 |
DATA: Hemoglobin A1c: 48.02% |
ACTION: - |
ACTION: - |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 6 |
DATA: Hyperdense area: no Sudden onset neuro sypmtoms: no |
DATA: Glucose: 196 Acute stroke symptoms: yes Age: 66 |
DATA: History: yes Blood Pressure: 119 |
DATA: Hemoglobin A1c: 28.17% |
ACTION: - |
ACTION: Monitor Hyperglycemia-related Complications |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 7 |
DATA: Hyperdense area: no Sudden onset neuro sypmtoms: yes |
DATA: Glucose: 215 Acute stroke symptoms: no Age: 38 |
DATA: History: no Blood Pressure: 169 |
DATA: Hemoglobin A1c: 62.92% |
ACTION: - |
ACTION: - |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 8 |
DATA: Hyperdense area: yes Sudden onset neuro sypmtoms: no |
DATA: Glucose: 207 Acute stroke symptoms: yes Age: 89 |
DATA: History: no Blood Pressure: 70 |
DATA: Hemoglobin A1c: 41.12% |
ACTION: - |
ACTION: Monitor Hyperglycemia-related Complications |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 9 |
DATA: Hyperdense area: no Sudden onset neuro sypmtoms: no |
DATA: Glucose: 176 Acute stroke symptoms: yes Age: 80 |
DATA: History: yes Blood Pressure: 140 |
DATA: Hemoglobin A1c: 89.50% |
ACTION: - |
ACTION: - |
ACTION: - |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
|
Patient 10 |
DATA: Hyperdense area: no Sudden onset neuro sypmtoms: yes |
DATA: Glucose: 159 Acute stroke symptoms: no Age: 20 |
DATA: History: yes Blood Pressure: 151 |
DATA: Hemoglobin A1c: 41.17% |
ACTION: - |
ACTION: - |
ACTION: Initiate Blood Pressure Management |
ACTION: Initiate Closer Monitoring and Optimization of Glucose Control |
Mezura Systems Ltd.
C/O Unit 4, Kinetica, 13 Ramsgate Street, London, Greater London, United Kingdom, E8 2FD
info [at] mezura.co.uk